IPCA Laboratories

IPCA Laboratories Goodwill

The Goodwill of IPCA Laboratories (IPCALAB.NS) as of Oct 27, 2026 is 828.10 M INR. In the previous year, Goodwill was 905.80 M INR — a change of -8.58% (lower).

Goodwill

828.10 MINR

YoY

-8.58%

Last updated:

Goodwill of IPCA Laboratories is 2026 828.10 M INR. Goodwill of IPCA Laboratories was 2025 905.80 M INR. It decreases by -8.58% lower compared to the previous year.

The IPCA Laboratories Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2019
472.00 M INR
Jan 1, 2020
624.40 M INR
Jan 1, 2021
466.00 M INR
Jan 1, 2022
388.40 M INR
Jan 1, 2023
381.40 M INR
Jan 1, 2024
905.80 M INR
Jan 1, 2025
905.80 M INR
Jan 1, 2026
828.10 M INR
The IPCA Laboratories Goodwill history
YEARGoodwillYoY
828.10 MINR-8.58%
905.80 MINR0.00%
905.80 MINR+137.49%
381.40 MINR-1.80%
388.40 MINR-16.65%
466.00 MINR-25.37%
624.40 MINR+32.29%
472.00 MINR0.00%
472.00 MINR0.00%
472.00 MINR0.00%
472.00 MINR-18.69%
580.50 MINR+25.70%
461.80 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IPCA Laboratories Stock analysis

What does IPCA Laboratories do? Ipca Laboratories Ltd. generates revenue through the manufacturing and marketing of over 350 pharmaceutical formulations and approximately 80 active pharmaceutical ingredients (APIs), including Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts, and Propranolol. The company sells its branded products such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, and Venpower in more than 100 countries globally. Its subsidiaries, Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd, and Tonira Exports Limited, support the distribution and sales of these products across international markets. The company's primary customers are healthcare providers, hospitals, and pharmacies in over 100 countries, purchasing both generic APIs and branded formulations. Manufacturing units in India produce APIs and formulations, with the firm's subsidiaries facilitating global market access. The therapeutic segments covered by its products include cardiovascular, antimalarial, and gastrointestinal treatments, among others, driven by the demand for cost-effective pharmaceutical solutions. IPCA Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IPCA Laboratories stock

Goodwill of IPCA Laboratories is 828.10 M INR in 2026.

Goodwill of IPCA Laboratories changed from 905.80 M INR to 828.10 M INR, representing a -8.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill IPCA Laboratories since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's IPCA Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — IPCA Laboratories

All Key Metrics — IPCA Laboratories